Sara Dunn

Bio:

Sara Dunn is a healthcare corporate affairs leader known for uniting scientific insight with clear, business-driven storytelling. She is deeply committed to translating rigorous evidence into strategies that advance patient outcomes and deliver business results.

Her work has shaped global action for people living with multiple sclerosis, including a major research and economic modeling initiative that uncovered the indirect and repercussive costs of progressive multiple sclerosis—informing regulatory strategy and driving policy change across the US and Europe. She also led a global COVID-era campaign that brought urgent attention to the drop in cancer diagnoses, strengthening public engagement and driving lung cancer testing.

Sara holds an MBA from Johns Hopkins University in Healthcare Management and Corporate Finance, enhancing her ability to bridge science, strategy, and financial discipline. A committed mentor and team builder, she cultivates talent and fosters inclusive, high-impact teams.

Driven by curiosity, strategic clarity, and a passion for turning evidence into action, Sara brings a distinctive blend of scientific fluency and business acumen to every initiative—ensuring communications not only inform and inspire but also move organizations toward their strategic goals